BIOVAXYS ANNOUNCES WARRANT EXTENSION USA - English Deutschland - Deutsch
VANCOUVER, BC
,
Aug. 10, 2022
/PRNewswire/ -- BioVaxys Technology Corp. (
CSE: BIOV, FRA: 5LB, OTCQB: BVAXF)
(
"
BioVaxys
" or the "
Company
") announces that it has extended the expiry date of 4,483,689 share purchase warrants with an...
Zur Pressemeldung auf www.prnewswire.com